Saturn V Capital Management Lp Portfolio Stock Holdings

Saturn V Capital Management Lp disclosed 21 stock positions valued at approximately $552.2 million in its latest SEC 13F filing. The largest holdings include ALUMIS INC, AMYLYX PHARMACEUTICALS INC, and ABIVAX SA. The filing reflects positions held as of March 31, 2026 and was filed on May 15, 2026.

Report Period
March 31, 2026
No. of Stocks
21
Portfolio Value
$552.2M
Holdings by Sector
Saturn V Capital Management Lp Portfolio Holdings in Q1 2026

16 holdings in the latest reporting period.

Page 1 of 1
CompanySymbolSectorPortfolio %SharesChange (Shares)Change %Value
ALUMIS INCALMSHealthcare12.77%3,202,075+66,122+2.11%$70,541,712
AMYLYX PHARMACEUTICALS INCAMLXHealthcare10.95%4,349,885-146,602-3.26%$60,463,402
ABIVAX SAABVXHealthcare10.94%542,696-106,483-16.40%$60,429,200
VAXCYTE INCPCVXHealthcare8.68%824,532+25,592+3.20%$47,913,555
PHARVARIS N VPHVSOther6.15%1,201,402+61,369+5.38%$33,939,606
IMMIX BIOPHARMA INCIMMXHealthcare6.09%3,693,585+694,416+23.15%$33,648,559
CELCUITY INCCELCHealthcare5.83%281,904-35,191-11.10%$32,176,523
DISC MEDICINE INCIRONHealthcare5.21%449,926+151,497+50.76%$28,768,268
COGENT BIOSCIENCES INCCOGTHealthcare4.37%626,635-590,429-48.51%$24,119,181
DYNE THERAPEUTICS INCDYNHealthcare3.17%966,609-822,007-45.96%$17,524,621
INVIVYD INCIVVDHealthcare2.58%10,949,084+3,213,698+41.55%$14,233,809
CANDEL THERAPEUTICS INCCADLHealthcare2.57%2,896,588+2,896,588+100.00%$14,193,281
OCULIS HOLDING AGH5870P102Other2.49%516,761--$13,740,675
OVID THERAPEUTICS INCOVIDHealthcare1.68%4,166,666+1,666,666+66.67%$9,249,999
INHIBIKASE THERAPEUTICS INCIKTHealthcare1.18%3,863,445+6,646+0.17%$6,490,588
ALTO NEUROSCIENCE INCANROHealthcare0.36%88,999+88,999+100.00%$2,000,698